Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers

Journal of Experimental Medicine

Volumn 204, Issue 5, 2007, Pages 1049-1056

  Sood, Rashmi ^a   Zogg, Mark ^a   Westrick, Randal J ^b   Guo, Yi He ^a   Kerschen, Edward J ^a   Girardi, Guillermina ^c   Salmon, Jane E ^c   Coughlin, Shaun R ^d   Weiler, Hartmut ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEINASE ACTIVATED RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FETUS WASTAGE; GENETIC DISORDER; GENETIC RISK; INFARCTION; INNER EAR; MORPHOGENESIS; MOUSE; NONHUMAN; PERFUSION; PLACENTA; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN DEPLETION; THROMBOCYTE; THROMBOPHILIA; THROMBOSIS;

ACTIVATED PROTEIN C RESISTANCE; ANIMALS; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; FACTOR V; FEMALE; FETAL DEATH; FETAL DISEASES; MICE; MICE, INBRED C57BL; PLACENTA; POINT MUTATION; PREGNANCY; PREGNANCY OUTCOME; RECEPTORS, THROMBIN; RISK FACTORS; THROMBOMODULIN;

EID: 34249051898     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20062566     Document Type: Article

References (34)

1. Dudding, T.E., and J. Attia. 2004. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb. Haemost. 91:700-711.
2. Rey, E., S.R. Kahn, M. David, and I. Shrier. 2003. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 361:901-908.
3. Kovalevsky, G., C.R. Gracia, J.A. Berlin, M.D. Sammel, and K.T. Barnhart. 2004. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Arch. Intern. Med. 164:558-563.
4. Mousa, H.A., and Z. Alfirevic. 2000. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum. Reprod. 15:1830-1833.
5. Sikkema, J.M., A. Franx, H.W. Bruinse, N.G. van der Wijk, H.W. de Valk, and P.G. Nikkels. 2002. Placental pathology in early onset pre-eclampsia and intra-uterine growth restriction in women with and without thrombophilia. Placenta. 23:337-342.
6. Brenner, B., R. Hoffman, H. Carp, M. Dulitsky, and J. Younis. 2005. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J. Thromb. Haemost. 3:227-229.
7. Gris, J.C., E. Mercier, I. Quere, G. Lavigne-Lissalde, E. Cochery-Nouvellon, M. Hoffet, S. Ripart-Neveu, M.L. Tailland, M. Dauzat, and P. Mares. 2004. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 103:3695-3699.
8. Carp, H., M. Dolitzky, and A. Inbal. 2003. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J. Thromb. Haemost. 1:433-438.
9. Sanson, B.J., A.W. Lensing, M.H. Prins, J.S. Ginsberg, Z.S. Barkagan, E. Lavenne-Pardonge, B. Brenner, M. Dulitzky, J.D. Nielsen, Z. Boda, et al. 1999. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb. Haemost. 81:668-672.
10. Walker, I.D., J.L. Kujovich, I.A. Greer, E. Rey, M. David, J.E. Salmon, B.J. Hunt, R.B. Zotz, A. Gerhardt, R.E. Scharf, et al. 2005. The use of LMWH in pregnancies at risk: new evidence or perception? J. Thromb. Haemost. 3:778-793.
11. Gris, J.C., and P. Mares. 2005. The long and winding road...towards LMWH for pregnancy loss. J. Thromb. Haemost. 3:224-226.
12. Lindqvist, P.G., and J. Merlo. 2005. Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence? J. Thromb. Haemost. 3:221-223.
13. Cui, J., D.T. Eitzman, R.J. Westrick, P.D. Christie, Z.J. Xu, A.Y. Yang, A.A. Purkayastha, T.L. Yang, A.L. Metz, K.P. Gallagher, et al. 2000. Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood. 96:4222-4226.
14. Isermann, B., S.B. Hendrickson, K. Hutley, M. Wing, and H. Weiler. 2001. Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block. Development. 128:827-838.
15. Isermann, B., R. Sood, R. Pawlinski, M. Zogg, S. Kalloway, J.L. Degen, N. Mackman, and H. Weiler. 2003. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat. Med. 9:331-337.
16. Li, W., X. Zheng, J.M. Gu, G.L. Ferrell, M. Brady, N.L. Esmon, and C.T. Esmon. 2005. Extra-embryonic expression of EPCR is essential for embryonic viability. Blood. 106:2716-2722.
17. Weiler-Guettler, H., P.D. Christie, D.L. Beeler, A.M. Healy, W.W. Hancock, H. Rayburn, J.M. Edelberg, and R.D. Rosenberg. 1998. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J. Clin. Invest. 101:1983-1991.
18. Eitzman, D.T., R.J. Westrick, X. Bi, S.L. Manning, J.E. Wilkinson, G.J. Broze, and D. Ginsburg. 2002. Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden. Circulation. 105:2139-2142.
19. Sood, R., S. Kalloway, A.E. Mast, C.J. Hillard, and H. Weiler. 2006. Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. Blood. 107:3173-3180.
20. Castellino, F.J., Z. Liang, S.P. Volkir, E. Haalboom, J.A. Martin, M.J. Sandoval-Cooper, and E.D. Rosen. 2002. Mice with a severe deficiency of the endothelial protein C receptor gene develop, survive, and reproduce normally, and do not present with enhanced arterial thrombosis after challenge. Thromb. Haemost. 88:462-472.
21. Ohlin, A.K., L. Norlund, and R.A. Marlar. 1997. Thrombomodulin gene variations and thromboembolic disease. Thromb. Haemost. 78:396-400.
22. Le Flem, L., V. Picard, J. Emmerich, S. Gandrille, J.N. Fiessinger, M. Aiach, and M. Alhenc-Gelas. 1999. Mutations in promoter region of thrombomodulin and venous thromboembolic disease. Arterioscler. Thromb. Vasc. Biol. 19:1098-1104.
23. Biguzzi, E., G. Merati, P.C. Liaw, P. Bucciarelli, N. Oganesyan, D. Qu, J.M. Gu, R. Fetiveau, C.T. Esmon, P.M. Mannucci, and E.M. Faioni. 2001. A 23bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function. Thromb. Haemost. 86:945-948.
24. von Depka, M., A. Czwalinna, R. Eisert, C. Wermes, I. Scharrer, A. Ganser, and S. Ehrenforth. 2001. Prevalence of a 23bp insertion in exon 3 of the endothelial cell protein C receptor gene in venous thrombophilia. Thromb. Haemost. 86:1360-1362.
25. Kunz, G., A.K. Ohlin, A. Adami, B. Zoller, P. Svensson, and D.A. Lane. 2002. Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function. Blood. 99:3646-3653.
26. Lissalde-Lavigne, G., P. Fabbro-Peray, E. Cochery-Nouvellon, E. Mercier, S. Ripart-Neveu, J.P. Balducchi, J.P. Daures, T. Perneger, I. Quere, M. Dauzat, et al. 2005. Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control 'NOHA first' study. J. Thromb. Haemost. 3:2178-2184.
27. Girardi, G., J. Berman, P. Redecha, L. Spruce, J.M. Thurman, D. Kraus, T.J. Hollmann, P. Casali, M.C. Caroll, R.A. Wetsel, et al. 2003. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J. Clin. Invest. 112:1644-1654.
28. Zhou, Y., M. McMaster, K. Woo, M. Janatpour, J. Perry, T. Karpanen, K. Alitalo, C. Damsky, and S.J. Fisher. 2002. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am. J. Pathol. 160:1405-1423.
29. Ma, L., M.D. Hollenberg, and J.L. Wallace. 2001. Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist. Br. J. Pharmacol. 134:701-704.
30. Sato, Y., H. Fujiwara, B.X. Zeng, T. Higuchi, S. Yoshioka, and S. Fujii. 2005. Platelet-derived soluble factors induce human extravillous trophoblast migration and differentiation: platelets are a possible regulator of trophoblast infiltration into maternal spiral arteries. Blood. 106:428-435.
31. Lay, A.J., Z. Liang, E.D. Rosen, and F.J. Castellino. 2005. Mice with a severe deficiency in protein C display prothrombotic and proinflammatory phenotypes and compromised maternal reproductive capabilities. J. Clin. Invest. 115:1552-1561.
32. Huang, Z.F., D. Higuchi, N. Lasky, and G.J. Broze Jr. 1997. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood. 90:944-951.
33. Isermann, B., S.B. Hendrickson, M. Zogg, M. Wing, M. Cummiskey, Y.Y. Kisanuki, M. Yanagisawa, and H. Weiler. 2001. Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis. J. Clin. Invest. 108:537-546.
34. Bergmeier, W., K. Rackebrandt, W. Schroder, H. Zirngibl, and B. Nieswandt. 2000. Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies. Blood. 95:886-893.